Tracking the emergence of SARS-CoV-2 alpha variant in the United Kingdom
Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom | New England
Journal of Medicine Skip to main content The New England Journal of Medicine homepage …
Journal of Medicine Skip to main content The New England Journal of Medicine homepage …
Evolution of viral quasispecies during SARS-CoV-2 infection
A Jary, V Leducq, I Malet, S Marot… - Clinical Microbiology …, 2020 - Elsevier
Objectives Studies are needed to better understand the genomic evolution of the recently
emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study aimed …
emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study aimed …
SARS-CoV-2 genome sequencing methods differ in their abilities to detect variants from low-viral-load samples
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic surveillance has
been vital in understanding the spread of coronavirus disease 2019 (COVID-19), the …
been vital in understanding the spread of coronavirus disease 2019 (COVID-19), the …
Evolution, mode of transmission, and mutational landscape of newly emerging SARS-CoV-2 variants
The recent emergence of multiple variants of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) has become a significant concern for public health worldwide. New …
2 (SARS-CoV-2) has become a significant concern for public health worldwide. New …
New SARS-CoV-2 variants—clinical, public health, and vaccine implications
SS Abdool Karim, T de Oliveira - New England Journal of …, 2021 - Mass Medical Soc
New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications | New England
Journal of Medicine Skip to main content The New England Journal of Medicine homepage …
Journal of Medicine Skip to main content The New England Journal of Medicine homepage …
COVID-19 vaccines vs variants—determining how much immunity is enough
R Rubin - Jama, 2021 - jamanetwork.com
As COVID-19 cases resulting from in-fection with SARS-CoV-2 variants accumulate in the
US and around the world, one question looms large: How well do the COVID-19 vaccines …
US and around the world, one question looms large: How well do the COVID-19 vaccines …
The emergence of SARS-CoV-2 variant lambda (C. 37) in South America
The evolution of SARS-CoV-2 variants with potentially increased transmissibility, virulence,
and resistance to antibody neutralization poses new challenges for the control of COVID-19 …
and resistance to antibody neutralization poses new challenges for the control of COVID-19 …
Introduction and expansion of the SARS-CoV-2 B. 1.1. 7 variant and reinfections in Qatar: A nationally representative cohort study
Background The epidemiology of the SARS-CoV-2 B. 1.1. 7 (or Alpha) variant is
insufficiently understood. This study's objective was to describe the introduction and …
insufficiently understood. This study's objective was to describe the introduction and …
[HTML][HTML] Sars-cov-2 b. 1.1. 529 (omicron) variant—united states, december 1–8, 2021
CDC Covid, R Team - Morbidity and Mortality Weekly Report, 2021 - ncbi.nlm.nih.gov
A new variant of SARS-CoV-2 (the virus that causes COVID-19), B. 1.1. 529 (Omicron)(1),
was first reported to the World Health Organization (WHO) by South Africa on November 24 …
was first reported to the World Health Organization (WHO) by South Africa on November 24 …
[HTML][HTML] SARS-CoV-2 variant B. 1.1. 7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
All current vaccines for COVID-19 utilize ancestral SARS-CoV-2 spike with the goal of
generating protective neutralizing antibodies. The recent emergence and rapid spread of …
generating protective neutralizing antibodies. The recent emergence and rapid spread of …